His suspension over bribery allegation was revoked on December 26
Dr S Eswara Reddy has rejoined the Central Drugs Standard Control Organisation (CDSCO) as joint drug controller after his suspension over a bribery allegation was revoked on December 26.
Reddy was suspended following his arrest by the Central Bureau of Investigation (CBI) in June, along with an associate vice-president of Biocon, on bribery charges in connection with waiving of Phase-3 clinical trials for an insulin injection.
The Delhi High Court in September had granted bail to Reddy who was then in judicial custody.
In October, Reddy had written to the Health Ministry seeking justice and revocation of his suspension orders, saying he was implicated in a “totally false case to deprive my promotion, tarnishing my image and damaging my reputation as an honest and sincere officer”.
He has now rejoined his earlier position in the apex drug regulatory body.
